BARCLAYS PLC - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 41 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$6,000
-53.8%
3,678
-43.0%
0.00%
Q2 2021$13,000
-82.4%
6,453
-71.0%
0.00%
Q1 2021$74,000
+117.6%
22,278
+159.0%
0.00%
Q4 2020$34,000
+9.7%
8,601
-29.1%
0.00%
Q3 2020$31,000
-31.1%
12,133
-16.7%
0.00%
Q2 2020$45,000
+181.2%
14,564
+74.3%
0.00%
Q1 2020$16,000
-91.4%
8,356
-67.2%
0.00%
Q4 2019$187,000
+216.9%
25,438
+93.3%
0.00%
Q3 2019$59,000
-59.6%
13,158
-10.1%
0.00%
Q2 2019$146,000
+65.9%
14,630
+93.9%
0.00%
Q1 2019$88,000
-38.5%
7,546
-10.2%
0.00%
Q3 2018$143,000
+429.6%
8,406
+433.0%
0.00%
Q2 2018$27,0001,5770.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Clal Insurance Enterprises Holdings Ltd 4,306$585,000,0000.63%
DAFNA Capital Management LLC 205,825$1,515,0000.52%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$15,413,0000.37%
Altshuler Shaham Ltd 1,095,018$8,060,0000.23%
MEITAV INVESTMENT HOUSE LTD 338,655$2,493,0000.18%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 125,900$927,0000.01%
HRT FINANCIAL LP 23,214$170,0000.01%
Squarepoint Ops LLC 63,736$469,0000.00%
Paloma Partners Management Co 16,318$120,0000.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 152,932$1,126,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders